A Novel Multiplex qRT-PCR Assay to Detect SARS-CoV-2 Infection: High Sensitivity and Increased Testing Capacity.

COVID-19 SARS-CoV-2 direct multiplex qRT-PCR multiplex qRT-PCR qRT-PCR

Journal

Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893

Informations de publication

Date de publication:
17 Jul 2020
Historique:
received: 23 06 2020
revised: 13 07 2020
accepted: 14 07 2020
entrez: 26 7 2020
pubmed: 28 7 2020
medline: 28 7 2020
Statut: epublish

Résumé

Rapid and sensitive screening of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is essential to limit the spread of the global pandemic we are facing. Quantitative real-time reverse transcription-polymerase chain reaction (qRT-PCR) is currently used for the clinical diagnosis of SARS-CoV-2 infection using nasopharyngeal swabs, tracheal aspirates, or bronchoalveolar lavage (BAL) samples. Despite the high sensitivity of the qRT-PCR method, false negative outcomes might occur, especially in patients with a low viral load. Here, we developed a multiplex qRT-PCR methodology for the simultaneous detection of SARS-CoV-2 genome (

Identifiants

pubmed: 32708870
pii: microorganisms8071064
doi: 10.3390/microorganisms8071064
pmc: PMC7409169
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Ricerca Sanitaria Finalizzata Giovani Ricercatori
ID : GR-2018-12365776
Organisme : Worldwide Cancer Research
ID : 20-0033
Pays : United Kingdom

Références

Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Clin Chim Acta. 2020 Aug;507:139-142
pubmed: 32335089
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
N Engl J Med. 2020 Mar 5;382(10):929-936
pubmed: 32004427
Eur J Clin Microbiol Infect Dis. 2020 Jun;39(6):1059-1061
pubmed: 32342252
Clin Chem. 2020 Apr 1;66(4):549-555
pubmed: 32031583
Am J Clin Pathol. 2020 May 5;153(6):706-708
pubmed: 32227199

Auteurs

Sara Petrillo (S)

Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.
Molecular Biotechnology Center, Via Nizza 52, 10126 Torino, Italy.

Giovanna Carrà (G)

Molecular Biotechnology Center, Via Nizza 52, 10126 Torino, Italy.
Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano, Italy.

Paolo Bottino (P)

Department of Public Health and Pediatrics, Microbiology and Virology Unit, Azienda Ospedaliero Universitaria "Città della Salute e della Scienza", University of Torino, 10126 Torino, Italy.

Elisa Zanotto (E)

Department of Public Health and Pediatrics, Microbiology and Virology Unit, Azienda Ospedaliero Universitaria "Città della Salute e della Scienza", University of Torino, 10126 Torino, Italy.

Maria Chiara De Santis (MC)

Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.
Molecular Biotechnology Center, Via Nizza 52, 10126 Torino, Italy.

Jean Piero Margaria (JP)

Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.
Molecular Biotechnology Center, Via Nizza 52, 10126 Torino, Italy.

Alessandro Giorgio (A)

Molecular Biotechnology Center, Via Nizza 52, 10126 Torino, Italy.

Giorgia Mandili (G)

Molecular Biotechnology Center, Via Nizza 52, 10126 Torino, Italy.

Miriam Martini (M)

Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.
Molecular Biotechnology Center, Via Nizza 52, 10126 Torino, Italy.

Rossana Cavallo (R)

Department of Public Health and Pediatrics, Microbiology and Virology Unit, Azienda Ospedaliero Universitaria "Città della Salute e della Scienza", University of Torino, 10126 Torino, Italy.

Davide Barberio (D)

Molecular Biotechnology Center, Via Nizza 52, 10126 Torino, Italy.

Fiorella Altruda (F)

Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.
Molecular Biotechnology Center, Via Nizza 52, 10126 Torino, Italy.

Classifications MeSH